Vectus Biosystems Limited (ASX:VBS)

Vectus Biosystems Revenue

In the fiscal year ending June 30, 2026, Vectus Biosystems had annual revenue of 2.77M AUD with 478.66% growth. Vectus Biosystems had revenue of 2.76M in the half year ending June 30, 2026, with 463.01% growth.

• Revenue: 2.77M
• Revenue Growth: +478.66%
• P/S Ratio: 3.23
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.95M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	2.77M	2.29M	478.66%
Jun 30, 2025	478.18K	-660.49K	-58.01%
Jun 30, 2024	1.14M	-215.86K	-15.94%
Jun 30, 2023	1.35M	54.45K	4.19%
Jun 30, 2022	1.30M	282.09K	27.71%

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error